1. Market Research
  2. > Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review

Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pfizer Inc. (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. It offers products for the treatment of respiratory, cardiovascular and metabolic diseases and conditions, infection, inflammation, cancer, ophthalmic diseases, neurological problems, pain, tissue repair, gastrointestinal diseases, women’s health issues, orphan diseases and genitourinary infections, among others. The company also develops small molecules, biologics and vaccines. Pfizer sells prescription pharmaceutical products through wholesalers, besides selling them directly to retailers, hospitals, clinics, government agencies and pharmacies. It sells consumer healthcare products through pharmacies, retail chains, distributors and grocery and convenience stores. The company has operations across the Americas, Asia-Pacific, Europe and the Middle East and Africa. Pfizer is headquartered in New York, the US.

Pfizer Inc. Key Recent Developments

Feb 29, 2016: GNS Healthcare Study with Pfizer Reveals Discovery of Novel Clinical Risk Factors Driving Progression to Type 2 Diabetes and Prediabetes
Feb 22, 2016: The Breast Cancer Research Foundation Launches First-of-Its-Kind Breast Cancer Clinical Research Funding Model
Feb 08, 2016: Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction
Feb 02, 2016: Pfizer Reports Fourth-Quarter And Full-Year 2015 Results Provides 2016 Financial Guidance
Jan 08, 2016: Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Pfizer Inc. - Key Facts 6
Pfizer Inc. - Key Employees 7
Pfizer Inc. - Key Employee Biographies 9
Pfizer Inc. - Major Products and Services 10
Pfizer Inc. - Pharmaceutical Pipeline Products Data 12
Pfizer Inc., Pipeline Products by Therapy Area 12
Pfizer Inc., Pipeline Products by Development Phase 13
Pfizer Inc. - History 27
Pfizer Inc. - Company Statement 50
Pfizer Inc. - Locations And Subsidiaries 51
Head Office 51
Other Locations and Subsidiaries 51
Affiliate 75
Joint Venture 75
Section 2 - Company Analysis 76
Pfizer Inc. - Business Description 76
Pfizer Inc. - Corporate Strategy 78
Pfizer Inc. - SWOT Analysis 79
SWOT Analysis - Overview 79
Pfizer Inc. - Strengths 79
Strength - Improved Performance of Innovative Products Business 79
Strength - Dominant Position 79
Strength - Emphasis on Research and Development Activities 79
Pfizer Inc. - Weaknesses 80
Weakness - Product Defects 80
Weakness - Discontinued Projects 80
Weakness - Declining Performance Global Established Pharmaceutical Division 80
Pfizer Inc. - Opportunities 81
Opportunity - Promising Product Pipeline 81
Opportunity - Significant Agreements and Collaboration 81
Opportunity - Strategic Acquisitions 81
Pfizer Inc. - Threats 82
Threat - Competitive Landscape 82
Threat - Government Regulations 82
Threat - Patent Expiry 82
Pfizer Inc. - Key Competitors 83
Section 3 - Company Financial Ratios 84
Financial Ratios - Capital Market Ratios 84
Financial Ratios - Annual Ratios 85
Performance Chart 87
Financial Performance 87
Financial Ratios - Interim Ratios 88
Financial Ratios - Ratio Charts 89
Section 4 - Company's Lifesciences Financial Deals and Alliances 90
Pfizer Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 90
Pfizer Inc., Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 91
Pfizer Inc., Recent Deals Summary 92
Section 5 - Company's Recent Developments 94
Feb 22, 2016: The Breast Cancer Research Foundation Launches First-of-Its-Kind Breast Cancer Clinical Research Funding Model 94
Feb 08, 2016: Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction 95
Feb 02, 2016: Pfizer Reports Fourth-Quarter And Full-Year 2015 Results Provides 2016 Financial Guidance 96
Jan 08, 2016: Pfizer Expands RandD Equity Investment Strategy to Access Early-Stage Scientific Innovations 101
Jan 04, 2016: FuelCell Energy Announces 5.6 Megawatt Fuel Cell Project With Pfizer 102
Jan 04, 2016: FuelCell Energy Announces 5.6 Megawatt Fuel Cell Project With Pfizer Inc. 103
Dec 07, 2015: Pfizer Awards Flagship OTC Product Manufacturing Contract To Catalent 104
Dec 04, 2015: Pfizer To Cease Operations At Granta Park RandD Facility In Cambridge 105
Nov 23, 2015: Morgan Lewis Serves as Lead U.S. Antitrust Counsel to Pfizer in Blockbuster Combination with Allergan 106
Nov 12, 2015: MSF launches global action against Pfizer and GlaxoSmithKline to cut the price of the pneumonia vaccine 107
Section 6 - Appendix 108
Methodology 108
Ratio Definitions 108
About GlobalData 112
Contact Us 112
Disclaimer 112

List of Tables
Pfizer Inc., Key Facts 6
Pfizer Inc., Key Employees 7
Pfizer Inc., Key Employee Biographies 9
Pfizer Inc., Major Products and Services 10
Pfizer Inc., Number of Pipeline Products by Therapy Area 12
Pfizer Inc., Number of Pipeline Products by Development Stage 13
Pfizer Inc., Pipeline Products By Therapy Area and Development Phase 14
Pfizer Inc., History 27
Pfizer Inc., Other Locations 51
Pfizer Inc., Subsidiaries 51
Pfizer Inc., Affiliate 75
Pfizer Inc., Joint Venture 75
Pfizer Inc., Key Competitors 83
Pfizer Inc., Ratios based on current share price 84
Pfizer Inc., Annual Ratios 85
Pfizer Inc., Interim Ratios 88
Pfizer Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 90
Pfizer Inc., Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 91
Pfizer Inc., Recent Deals Summary 92
Currency Codes 108
Capital Market Ratios 108
Equity Ratios 109
Profitability Ratios 109
Cost Ratios 110
Liquidity Ratios 110
Leverage Ratios 111
Efficiency Ratios 111

List of Figures
Pfizer Inc., Pipeline Products by Therapy Area 12
Pfizer Inc., Pipeline Products by Development Phase 13
Pfizer Inc., Performance Chart (2011 - 2015) 87
Pfizer Inc., Ratio Charts 89
Pfizer Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 90
Pfizer Inc., Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 91

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.